$AFL

AFLAC INC (AFL): Results of Operations and Financial Condition

AFLAC INC (AFL) filed an SEC Form 8-K — Results of Operations and Financial Condition. Aflac Incorporated Announces Second Quarter 2026 Results, Declares Third Quarter Dividend COLUMBUS, Ga. - August 6, 2026 - Aflac Incorporated (NYSE: AFL) today reported its second quarter results. For the Quarter • Total revenues were $4.1 billion, which was a 1.0% decrease year

Original reporting
Published Aug 6, 2026, 8:14 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 8:27 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$AFL
Neutral
medium confidence
Mentioned
$AFL
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$AFLNeutralLow
01

Why it matters

The key new tradable content is the detailed Q2 2026 segment and consolidated financial tables (adjusted earnings, net earnings, and per-share metrics) plus clarification that LDTI adoption changes deferred profit liability presentation without impacting net earnings.

02

Market read

For AFL, this supplement increases transparency into Q2 2026 earnings components and segment performance, but the excerpt does not show new guidance, a deal, or a regulatory action.

03

What to watch

If the market had not fully digested segment adjusted earnings, operating ratios, or investment results tables, the supplement could still shift near-term expectations for underwriting and investment income trends.

Relevance 7/10Novelty 4/10Timing: filed after market close, for Q2 2026 results supplement
alphai · Earnings readAFL · Second Quarter 2026 · ended June 30, 2026

Second-quarter 2026 GAAP net earnings were $825 million, while adjusted earnings were $883 million.

Mixed quarter

GAAP net earnings increased 37.7% year over year to $825 million, but adjusted earnings declined 7.7% to $883 million, total revenues declined 1.0%, and total net earned premiums declined 6.3%.

Revenue
$4,117 million
(1.0) y/y
EPS · non-GAAP
$1.75
(1.7) y/y

Key metrics

as reported
MetricValueq/qy/y
Gross premiumsGAAP$3,364 million
Assumed (ceded) premiumsGAAP$(112) million
Total net earned premiumsGAAP$3,252 million(6.3) %
Net investment incomeGAAP$984 million(9.0)
Net investment gains (losses)GAAP$(153) million
Other incomeGAAP$34 million
Total revenuesGAAP$4,117 million(1.0)
Incurred claims - directGAAP$2,160 million
Incurred claims - assumed (ceded)GAAP$(61) million
Increase in FPB - directGAAP$(183) million
Increase in FPB - assumed (ceded)GAAP$(18) million
Total net benefits and claims, excluding reserve remeasurementGAAP$1,898 million
Reserve remeasurement (gain) lossGAAP$(46) million
Total net benefits and claimsGAAP$1,852 million(7.9)
Amortization of DACGAAP$218 million
Insurance commissionsGAAP$239 million
Insurance expensesGAAP$749 million
Interest expenseGAAP$64 million
Total acquisition and operating expensesGAAP$1,270 million(4.4)
Total benefits and expensesGAAP$3,122 million(6.5)
Pretax earningsGAAP$995 million
Income tax expense (benefit)GAAP$170 million
Net earningsGAAP$825 million37.7 %
Effective Tax rateGAAP17.0 %
Net earnings per share of common stock - basicGAAP$1.64 per share46.4
Net earnings per share of common stock - dilutedGAAP$1.63 per share46.8
Aflac Japan pretax adjusted earningsnon-GAAP$741 million(6.2) %
Aflac U.S. pretax adjusted earningsnon-GAAP$370 million(4.6)
Corporate and other pretax adjusted earningsnon-GAAP$(10) million
Pretax adjusted earningsnon-GAAP$1,101 million(8.1)
Income taxesnon-GAAP$218 million(9.5)
Adjusted earningsnon-GAAP$883 million(7.7)
Adjusted net investment gains (losses)non-GAAP$(106) million
Other and non-recurring income (loss)non-GAAP
Income tax benefit (expense) on items excluded from adjusted earningsnon-GAAP$48 million
Adjusted earnings per share - basicnon-GAAP$1.75 per share(1.7) %
Adjusted earnings per share - dilutednon-GAAP$1.75 per share(1.7)

Capital returns

  • 8,521 shares purchased QTD (In Thousands).
  • 502,257 ending shares outstanding (In Thousands).
  • 505,578 QTD weighted average diluted shares (In Thousands).

What drove it

  • Total net earned premiums declined 6.3% to $3,252 million.
  • Total net benefits and claims declined 7.9% to $1,852 million.
  • Total acquisition and operating expenses declined 4.4% to $1,270 million.
  • GAAP net investment gains (losses) were $(153) million, compared with $(421) million.
  • The effective tax rate was 17.0%, compared with 27.0%.

Concerns

  • Adjusted earnings declined 7.7% to $883 million and adjusted diluted earnings per share declined 1.7% to $1.75 per share.
  • Net investment income declined 9.0% to $984 million.
  • Aflac Japan pretax adjusted earnings declined 6.2% to $741 million.
  • Aflac U.S. pretax adjusted earnings declined 4.6% to $370 million.
  • Corporate and other pretax adjusted earnings were $(10) million, compared with $20 million.

What to watch

  • Total net earned premiums and gross premiums.
  • Net investment income and net investment gains (losses).
  • Aflac Japan and Aflac U.S. pretax adjusted earnings.
  • Benefits and claims trends, including reserve remeasurement.
  • Cash and cash equivalents and notes payable.

Balance sheet and cash flow

  • Cash and cash equivalents were $6,120 million as of June 30, 2026, compared with $6,965 million as of June 30, 2025.
  • Total investments and cash were $103,003 million as of June 30, 2026, compared with $111,769 million as of June 30, 2025.
  • Total assets were $115,961 million as of June 30, 2026, compared with $124,736 million as of June 30, 2025.
  • Notes payable were $8,729 million as of June 30, 2026, compared with $8,933 million as of June 30, 2025.
  • Total policy liabilities were $64,348 million as of June 30, 2026, compared with $78,904 million as of June 30, 2025.
  • Total liabilities were $85,649 million as of June 30, 2026, compared with $97,536 million as of June 30, 2025.

Analysis

Aflac reported second-quarter 2026 GAAP net earnings of $825 million, up 37.7% from $599 million. Diluted GAAP earnings per share were $1.63, up 46.8% from $1.11. The GAAP result included net investment losses of $(153) million, compared with $(421) million in the prior-year quarter. Adjusted net investment gains (losses) were $(106) million, compared with $(377) million.

Underlying adjusted results moved in the opposite direction. Adjusted earnings declined 7.7% to $883 million, while adjusted diluted earnings per share declined 1.7% to $1.75. Pretax adjusted earnings declined 8.1% to $1,101 million. Aflac Japan pretax adjusted earnings declined 6.2% to $741 million and Aflac U.S. pretax adjusted earnings declined 4.6% to $370 million.

Reported revenue was $4,117 million, down 1.0%, as total net earned premiums declined 6.3% to $3,252 million and net investment income declined 9.0% to $984 million. Total benefits and expenses declined 6.5% to $3,122 million. Total net benefits and claims declined 7.9% to $1,852 million, while total acquisition and operating expenses declined 4.4% to $1,270 million.

The effective tax rate was 17.0%, compared with 27.0%. On the balance sheet, cash and cash equivalents were $6,120 million and notes payable were $8,729 million at June 30, 2026. The company reported 8,521 shares purchased QTD, with ending shares outstanding of 502,257, in thousands.

No forward guidance, management commentary, dividend amount, repurchase dollar amount, operating cash flow, or free cash flow was included in the supplied filing text. The main reported items to monitor are premium trends, investment income, the adjusted earnings performance of Aflac Japan and Aflac U.S., and the relationship between GAAP earnings and adjusted results.

Not in the filing

stated, not guessed
  • Forward guidance
  • Previous-period outlook for guidance comparison
  • Segment revenue
  • Gross margin
  • Operating margin
  • Operating cash flow
  • Free cash flow
  • Dividend amount
  • Share repurchase dollar amount
  • Total debt beyond notes payable
  • Management commentary
  • Named executive quotes
  • Complete balance-sheet presentation beyond the supplied truncated filing text

AlphaAI analysis generated from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure was cross-checked against the filing text; consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Background

The document is Aflac Incorporated’s SEC Form 8-K (Item 2.02) attaching a financial supplement for its quarterly earnings release, including non-U.S. GAAP adjusted measures and LDTI accounting presentation.

Company-level read

Ticker impact

$AFLNeutralMedium confidence
Context

Aflac’s 8-K includes its Q2 2026 financial supplement with segment adjusted earnings and U.S. and Japan operating metrics.

Expected impact

Near-term price impact is likely limited unless the supplement’s numbers differ materially from what the market already priced from the earnings release.

Evidence & confidence

This is an SEC 8-K statistical supplement (Item 2.02) with detailed tables and accounting presentation context; it is informative but not a new earnings release or guidance change in the provided text.

Market effects

Adds incremental transparency into insurer earnings drivers (investment income, claims, reserve remeasurement) and LDTI-related presentation for long-duration contracts.

Highlights Aflac Japan and Aflac U.S. segment performance and yen/dollar sensitivity tables, relevant for regional insurer sentiment.

Limited global spillover; primarily company-specific disclosure for a U.S. insurer.

Counterpoint

Because the excerpt emphasizes accounting presentation (LDTI) and statistical tables, traders may discount it versus the headline earnings release and focus on any separate guidance or management commentary not shown here.

Key entities

  • Aflac Incorporated

    Subject issuer filing an 8-K with a Q2 2026 financial supplement and segment adjusted results.

  • Financial Accounting Standards Board (FASB) ASU 2018-12 / LDTI

    Long-duration targeted improvements adopted by Aflac as of Jan 1, 2023, affecting presentation of deferred profit liability changes.

Every AFL earnings report

This story covers one filing. The ticker page keeps them all: each quarter's reported metrics with year-over-year and sequential comparisons, segments, guidance, and how the numbers landed against the company's own prior outlook.

Related articles

$AFLMedAI 8/10

Aflac (AFL) Q2 2026 Earnings Call Transcript

Aflac (AFL) reported Q2 2026 net earnings per diluted share of $1.63, up 46.8% year over year, and adjusted EPS of $1.75, down 1.7% due to FX. Total revenues were $4.1 billion, down 1%. Capital return was $1.3 billion. Japan sales fell 5.6% and U.S. sales rose 2.6%.

$AFLMed

Aflac: Q2 Earnings Snapshot

Aflac Inc. (AFL) reported Q2 net income of $825 million, or $1.63 per share. Adjusted earnings were $1.75 per share, below Zacks’ average estimate of $1.77. Revenue was $4.12 billion, with adjusted revenue of $4.22 billion versus $4.19 billion expected. Shares closed at $126.23.

$TRVMed

Three 'Dividend Aristocrats' on Josh Brown's list in July's hottest sector

CNBC Pro’s Josh Brown and Sean Russo highlight three insurance “Dividend Aristocrats”: Travelers (TRV), Chubb (CB), and Aflac (AFL). Travelers reported Q2 core EPS $10.04 vs ~$5.39 consensus, with $2.2B income and AI-linked claims improvements; shares rose ~8%. Chubb and Aflac are noted for long dividend growth streaks and recent operating updates.

$AFLMed

Morgan Stanley Lifts Aflac (AFL) PT to $125 on Solid Insurance Trends

The article discusses AI’s potential economic impact, citing Elon Musk’s prediction of 10 billion humanoid robots by 2040 and a $250 trillion value estimate. It also claims Morgan Stanley raised its Aflac (AFL) price target to $125, and promotes newsletter subscriptions tied to an “underdog” stock priced around $3, alleging $100 million in waste cuts and “400% upside.”

$AFLMedAI 8/10

Morgan Stanley Lifts Aflac (AFL) PT to $125 on Solid Insurance Trends

Morgan Stanley raised its Aflac (AFL) price target to $125 from $120 and kept an Equal Weight rating, citing generally strong Q1 life insurance results, expected earnings momentum through 2026, steady international operations, and improving mortality trends. Separately, Piper Sandler cut its target to $125 from $130, citing Q1 earnings below estimates due to weaker Japan performance, though it noted improving Japan benefit ratios and strong distribution.